Q3 2024 Revenue Guidance -- Management expects RMB1.9 billion to RMB1.92 billion, implying growth of 18.2%-19.5% year over ...

Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...

Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) Q4 2026 Earnings Call Transcript March 31, 2026 Dave & Buster’s Entertainment, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, ...

MSC Industrial Direct Co., Inc. (NYSE:MSM) Q2 2026 Earnings Call Transcript April 1, 2026 MSC Industrial Direct Co., Inc. misses on earnings expectations. Reported EPS is $0.82 EPS, expectations were ...

Q4 2025 Earnings Call April 2, 2026 7:00 AM EDTCompany ParticipantsPatrick Maurer - Chief Financial OfficerConference ...

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

Q4 2025 Earnings Call March 31, 2026 5:00 PM EDTCompany ParticipantsGregory Poilasne - Co-Founder, CEO & DirectorDavid ...

GEN Restaurant Group, Inc. (NASDAQ:GENK) Q4 2025 Earnings Call Transcript March 31, 2026 GEN Restaurant Group, Inc. misses on ...

Preliminary Q4 revenue range -- $18.1 million-$30 million, driven by a single complex multiparty nonmonetary transaction for ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...

Discover how AI tools can enhance personal finance and investing strategies while navigating their limitations for optimal ...

The following is the transcript of the interview with Iran policy analyst Karim Sadjadpour and former CENTCOM commander and ...